These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 11802216)

  • 1. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82.
    Hashida H; Takabayashi A; Tokuhara T; Taki T; Kondo K; Kohno N; Yamaoka Y; Miyake M
    Int J Cancer; 2002 Feb; 97(4):518-25. PubMed ID: 11802216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients.
    Huang CI; Kohno N; Ogawa E; Adachi M; Taki T; Miyake M
    Am J Pathol; 1998 Sep; 153(3):973-83. PubMed ID: 9736046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung.
    Adachi M; Taki T; Huang C; Higashiyama M; Doi O; Tsuji T; Miyake M
    J Clin Oncol; 1998 Mar; 16(3):1060-7. PubMed ID: 9508191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
    Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
    Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer.
    Sho M; Adachi M; Taki T; Hashida H; Konishi T; Huang CL; Ikeda N; Nakajima Y; Kanehiro H; Hisanaga M; Nakano H; Miyake M
    Int J Cancer; 1998 Oct; 79(5):509-16. PubMed ID: 9761121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
    Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
    Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of transmembrane 4 superfamily in colon cancer.
    Hashida H; Takabayashi A; Tokuhara T; Hattori N; Taki T; Hasegawa H; Satoh S; Kobayashi N; Yamaoka Y; Miyake M
    Br J Cancer; 2003 Jul; 89(1):158-67. PubMed ID: 12838318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression.
    Adachi M; Taki T; Konishi T; Huang CI; Higashiyama M; Miyake M
    J Clin Oncol; 1998 Apr; 16(4):1397-406. PubMed ID: 9552043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of motility-related protein 1 (MRP1/CD9) and integrin alpha3 expression in endometrial cancers.
    Miyamoto S; Maruyama A; Okugawa K; Akazawa K; Baba H; Maehara Y; Mekada E
    Cancer; 2001 Aug; 92(3):542-8. PubMed ID: 11505398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
    Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
    Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel molecular staging protocol for non-small cell lung cancer.
    Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
    Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of KAI1/CD82 and MRP-1/CD9 in transitional cell carcinoma of bladder.
    Ai X; Zhang X; Wu Z; Ma X; Ju Z; Wang B; Shi T
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):79-82. PubMed ID: 17393117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel monoclonal antibody MH8-4 inhibiting cell motility recognizes integrin alpha 3: inverse of its expression withmetastases in colon cancer.
    Hashida H; Takabayashi A; Adachi M; Imai T; Kondo K; Kohno N; Yamaoka Y; Miyake M
    Int J Oncol; 2001 Jan; 18(1):89-95. PubMed ID: 11115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9.
    Mitsuzuka K; Handa K; Satoh M; Arai Y; Hakomori S
    J Biol Chem; 2005 Oct; 280(42):35545-53. PubMed ID: 16103120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of KAI1 expression in the progression of colorectal cancer.
    Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
    Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of KAI1, MRP-1, and FAK proteins in lung cancer detected by high-density tissue microarray].
    Wang XY; Liu T; Zhu CZ; Li Y; Sun R; Sun CY; Wang AX
    Ai Zheng; 2005 Sep; 24(9):1091-5. PubMed ID: 16159431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a splice variant of KAI1, a tumor metastasis suppressor gene, influences tumor invasion and progression.
    Lee JH; Seo YW; Park SR; Kim YJ; Kim KK
    Cancer Res; 2003 Nov; 63(21):7247-55. PubMed ID: 14612520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis.
    Higashiyama M; Kodama K; Yokouchi H; Takami K; Adachi M; Taki T; Ishiguro S; Nakamori S; Yoshie O; Miyake M
    Cancer; 1998 Aug; 83(3):466-74. PubMed ID: 9690539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance.
    Imai Y; Sasaki T; Shinagawa Y; Akimoto K; Fujibayashi T
    Oral Oncol; 2002 Sep; 38(6):557-61. PubMed ID: 12167433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model.
    Takeda T; Hattori N; Tokuhara T; Nishimura Y; Yokoyama M; Miyake M
    Cancer Res; 2007 Feb; 67(4):1744-9. PubMed ID: 17308116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.